Search Results
Jan 05, 2026, 07:00 ET NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board
announced the appointment of Dr. Julien Boisdron, MD, a seasoned diabetes expert with extensive experience in Swiss big pharma leadership to its Scientific Advisory Board ("SAB").
More news about: NewcelX Ltd.
Jan 05, 2026, 06:45 ET TELUS leadership, including Board of Directors and CEO, demonstrates confidence in the Company's future with share purchases
be read together with the risk factors and assumptions set out in our 2024 annual management's discussion and analysis ("MD&A"), and updated in our third quarter 2025 MD&A, and in other TELUS public disclosure documents and filings with securities commissions in Canada (on SEDAR+ at
More news about: TELUS Corporation
Jan 05, 2026, 06:45 ET TELUS leadership, including Board of Directors and CEO, demonstrates confidence in the Company's future with share purchases
be read together with the risk factors and assumptions set out in our 2024 annual management's discussion and analysis ("MD&A"), and updated in our third quarter 2025 MD&A, and in other TELUS public disclosure documents and filings with securities commissions in Canada (on SEDAR+ at
More news about: TELUS Corporation
Jan 05, 2026, 06:30 ET CGI completes the acquisition of Comarch Polska SA to accelerate expansion in Poland
in the section titled Risk Environment of CGI's annual MD&A, which is incorporated by reference in this cautionary statement. We also caution readers that the above-mentioned risks and the risks disclosed in CGI's annual MD&A and other documents and filings are not the only ones that could
More news about: CGI Inc.
Jan 05, 2026, 05:00 ET Earendil Labs Announces Strategic Collaboration with Sanofi to Discover Bispecific Antibodies for Autoimmune Diseases
collaboration underscores our commitment to advancing next-generation therapeutics that have the potential to set new standards of care."Zhenping Zhu, MD, PhD, President & co-CEO of Earendil Labs, added: "Autoimmune diseases impose a heavy burden on patients and healthcare systems alike, with many conditions
More news about: Earendil Labs
Jan 02, 2026, 16:00 ET McCormick Completes Acquisition of Controlling Interest in McCormick de Mexico
HUNT VALLEY, Md., Jan. 2, 2026 /PRNewswire/ -- McCormick & Company Inc. (NYSE: MKC) (the "Company"), a global leader in flavor, today announced that it has completed the acquisition of an additional 25% ownership interest
More news about: McCormick & Company, Incorporated
Jan 02, 2026, 12:58 ET Shield of Odin and Bespoke Concierge MD Announce Strategic Partnership Expanding Nationwide Access to Concierge Medical Care
permittedAll Bespoke Concierge MD physicians practice independently and in accordance with state licensing requirements, professional standards, and applicable telehealth laws.Physician Leadership PerspectiveDr. Zaid Fadul, MD, representing Bespoke Concierge MD, emphasized the clinical
More news about: Odin Industries LLC
Jan 02, 2026, 09:15 ET EQB announces renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
common shares ultimately available to be purchased pursuant to the NCIB as well as those factors discussed under the heading "Risk Management" in the MD&A and in the Company's documents filed on SEDAR+ at
More news about: EQB Inc.
Jan 02, 2026, 09:00 ET Origin AI Launches Compatible With Origin™ Program to Meet Industry Demand for Scalable WiFi Sensing and Accelerate Integration Across Global SoC Platforms
ROCKVILLE, Md., Jan. 2, 2026 /PRNewswire/ -- Origin AI™ today announced its Compatible With Origin™ program, a new initiative designed to enable WiFi sensing at scale across leading WiFi system-on-chip
More news about: Origin AI
Jan 02, 2026, 09:00 ET Affle Appoints Sameer Sondhi as Chief Strategic Investments Officer and CEO, North America
experience, a deep understanding of our business and a credible long-term commitment to our vision and culture" said Anuj Khanna Sohum, Chairperson, MD & CEO of Affle. "With Sameer's dual role, we are uniquely positioned to reinforce our organic growth momentum in North
More news about: Affle
Jan 02, 2026, 09:00 ET Orlando Health Network created new care models in 2025 amid growth outside Central Florida
more than 1,100 providers in Central Alabama."This year's report reflects more than growth — it showcases transformation," said Martin Soto, MD, board chairperson, Orlando Health Network. "As our network expanded, we built new care models that enable us to continue delivering high-quality, compassionate
More news about: Orlando Health
Jan 02, 2026, 07:12 ET Affle Appoints Sameer Sondhi as Chief Strategic Investments Officer and CEO, North America
expansion across North America, Europe and Asia. He holds a master's degree in computer science.Commenting on this, Anuj Khanna Sohum, Chairperson, MD & CEO of Affle, said, "Welcoming Sameer as CEO for North America marks a pivotal milestone in our journey and will elevate our business to even
More news about: Affle 3i Limited
Dec 31, 2025, 08:10 ET Donna Rae Garff Marriott, Cherished Wife, Mother, Grandmother, and Community Leader, Passes Away at Age 90
BETHESDA, Md., Dec. 31, 2025 /PRNewswire/ -- Marriott International announces with deep sadness the passing of Donna Rae Garff Marriott, a woman of grace, faith, and unwavering devotion to family. Mrs. Marriott passed away
More news about: Marriott International, Inc.
Dec 30, 2025, 10:10 ET The Skin of Color Society (SOCS) Reports an Impactful Year of Progress, Expansion, and Innovation Toward Advancing Knowledge and Excellence in Patient Care
awareness of and excellence within skin of color dermatology. through research, education, mentorship, and advocacy. Established in 2004 by Susan C. Taylor, MD, SOCS includes members from 22 countries around the world. Learn more:
More news about: Skin of Color Society
Dec 30, 2025, 08:00 ET CosmeticsMD Introduces Women's Wellness Services and Expands Brand to Cosmetics & Wellness MD
Wellness MD is able to offer a more integrated approach to care, where internal wellness and external aesthetics can work together to support balance, vitality, and confidence at every stage of life.Learn more at cosmeticsandwellnessmd.comAbout Cosmetics & Wellness MDCosmetics
More news about: Cosmetics & Wellness MD
Dec 29, 2025, 13:28 ET Tri-City Cardiology's Ambulatory Surgical Center Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care
maintaining rigorous standards for safety and clinical outcomes."Our ASC allows us to focus exclusively on cardiovascular care," said Jaskamal Kahlon, MD, interventional cardiologist at Tri-City Cardiology. "That specialization, combined with a highly trained clinical team, enables us to perform procedures
More news about: Tri-City Cardiology
Dec 29, 2025, 13:16 ET The Inner Circle acknowledges, Phyllis Heffner, MD as a Pinnacle Professional Member Inner Circle of Excellence
COLUMBIA, Md., Dec. 29, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Phyllis Heffner, MD is being acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for her contributions in the medical
More news about: The Inner Circle
Dec 29, 2025, 13:16 ET The Inner Circle acknowledges, John A. Murphy, MD, FACOG as a 2025 Life Achiever
2025 /PRNewswire/ -- Prominently featured in The Inner Circle, John A. Murphy, MD, FACOG is acknowledged as a 2025 Life Achiever for his contributions to Women's Health Care and Obstetrics. Dr. John A. Murphy, MD, FACOG, is a highly respected physician specializing in obstetrics, gynecology,
More news about: The Inner Circle
Dec 29, 2025, 08:00 ET SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study
esophageal cancers and realizing the promise of FAPI PET in precision medicine.""FAPI-74 is an exciting new advanced PET tracer" said Judith Rose, MD, RadNet's Director of PET/CT and Research. "RadNet's experience in PET/CT clinical trials, combined with our national network of advanced imaging capabilities
More news about: Sofie Biosciences
Dec 29, 2025, 08:00 ET BTQ Technologies Issues Year-End CEO Letter to Shareholders
technology sector. For a more comprehensive discussion of risks, please refer to the Company's most recent Management's Discussion and Analysis ("MD&A") and Annual Information Form ("AIF") filed on SEDAR+ at
More news about: BTQ Technologies Corp.
Dec 29, 2025, 07:00 ET UNITED VAN LINES 49TH ANNUAL MOVERS STUDY REVEALS FAMILY, JOBS AND RETIREMENT ARE FACTORS RESHAPING INTERSTATE MIGRATION IN THE U.S.
regions, continued to experience significant outbound migration. New Jersey (62%), New York (58%), and California (58%) led departures, with Hagerstown, MD (88%), Nassau-Suffolk, NY (78%), and Pueblo, CO (74%) recording the highest outbound activity United's city data.Moving InThe
More news about: United Van Lines
Dec 29, 2025, 06:00 ET Realtor.com®: It Takes 7 Years to Save for a Down Payment, Down From 2022 Peak of 12 Years
MetroJan - Nov 2025 Md DP2025 med HH income
More news about: Realtor.com
Dec 28, 2025, 20:58 ET Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates
construction in Yantai. Together, these elements ensure a sustainable, scalable, and rapidly innovating radiopharmaceutical pipeline.Jingsong Wang, MD, PhD, Founder, Chairman, and CEO of Harbour BioMed, commented: "We are very pleased to establish a long-term strategic collaboration with Lannacheng to
More news about: Harbour BioMed
Dec 26, 2025, 09:35 ET Tata Power, London School of Economics and Political Science (LSE) and International Growth Centre (IGC) launches Energy Insights and innovation lab to accelerate India's clean energy transition
integration in a way that is reliable, affordable, and aligned with India's net-zero goals.The Lab was inaugurated by Dr Praveer Sinha, CEO & MD, Tata Power; Prof. Robin Burgess, Professor of Economics and Director of IGC and EEE Research Program, LSE; Dr. Jonathan Leape, Executive Director, IGC
More news about: Tata Power
Dec 25, 2025, 03:45 ET China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Lilly, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.Guided by the motto, "Start with Integrity, Succeed through Action" Innovent maintains the highest standard of industry
More news about: Innovent Biologics